Immunology
-
MTX-COVAB, a human-derived antibody with potent neutralizing activity against SARS-CoV-2 infection in vitro and in a hamster model of COVID-19
This article has 12 authors:Reviewed by ScreenIT
-
The polybasic cleavage site in the SARS-CoV-2 spike modulates viral sensitivity to Type I IFN and IFITM2
This article has 7 authors:Reviewed by ScreenIT
-
The influence of major S protein mutations of SARS-CoV-2 on the potential B cell epitopes
This article has 2 authors:Reviewed by ScreenIT
-
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity
This article has 15 authors:Reviewed by ScreenIT
-
Rapid GMP-compliant expansion of SARS-CoV-2-specific T cells from convalescent donors for use as an allogeneic cell therapy for COVID-19
This article has 9 authors:Reviewed by ScreenIT
-
Persistent Cellular Immunity to SARS-CoV-2 Infection
This article has 10 authors:Reviewed by ScreenIT
-
Global Absence and Targeting of Protective Immune States in Severe COVID-19
This article has 40 authors:Reviewed by ScreenIT
-
Identification of Cross-Reactive CD8 + T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant Variants
This article has 20 authors:Reviewed by ScreenIT
-
Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates
This article has 27 authors:Reviewed by ScreenIT
-
Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues
This article has 19 authors:Reviewed by ScreenIT